Avidia, created in 2003 (United States), from 142 sister brands and 17477 competing brands. Avidia is a brand of Amgen, listed on the stock exchange of New York. Avidia is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Amgen
(Avidia)
over 5 years*
USD 401.68